- Shorla Oncology co-founder and CEO Sharon Cunningham was recently featured by YPO for her mission to deliver smarter, faster cancer treatments to underserved patient populations. As the EY Entrepreneur Of The Year™ 2025 Ireland winner, Sharon shared Shorla’s journey—from launching in 2018 with a focus on women and children’s oncology needs to building a portfolio of four FDA-approved drugs. Her story highlights how purpose-driven leadership and scientific innovation can create lasting impact in cancer care.
Read the full article on YPO’s website
